9-32986032-TAAAAAAAAA-TAAAAAAAAAA
Variant names:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001195248.2(APTX):c.484-3dupT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.020 ( 0 hom., cov: 0)
Exomes 𝑓: 0.0014 ( 3 hom. )
Consequence
APTX
NM_001195248.2 splice_region, intron
NM_001195248.2 splice_region, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.384
Genes affected
APTX (HGNC:15984): (aprataxin) This gene encodes a member of the histidine triad (HIT) superfamily. The encoded protein may play a role in single-stranded DNA repair through its nucleotide-binding activity and its diadenosine polyphosphate hydrolase activity. Mutations in this gene have been associated with ataxia-ocular apraxia. Alternatively spliced transcript variants have been identified for this gene.[provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 9-32986032-T-TA is Benign according to our data. Variant chr9-32986032-T-TA is described in ClinVar as [Benign]. Clinvar id is 2767545.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0203 (289/14240) while in subpopulation AFR AF= 0.0532 (270/5078). AF 95% confidence interval is 0.048. There are 0 homozygotes in gnomad4. There are 134 alleles in male gnomad4 subpopulation. Median coverage is 0. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0202 AC: 288AN: 14246Hom.: 0 Cov.: 0
GnomAD3 genomes
AF:
AC:
288
AN:
14246
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00145 AC: 1038AN: 717576Hom.: 3 Cov.: 10 AF XY: 0.00152 AC XY: 563AN XY: 370954
GnomAD4 exome
AF:
AC:
1038
AN:
717576
Hom.:
Cov.:
10
AF XY:
AC XY:
563
AN XY:
370954
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0203 AC: 289AN: 14240Hom.: 0 Cov.: 0 AF XY: 0.0203 AC XY: 134AN XY: 6598
GnomAD4 genome
AF:
AC:
289
AN:
14240
Hom.:
Cov.:
0
AF XY:
AC XY:
134
AN XY:
6598
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Dec 11, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at